Summary
- Current Price
- As of today, IMVT price is $44.30, up +1.35% on
- Current Price All-Time High
- IMVT price is currently -17.58% below its historical high of $53.75 set on
- Market Cap
- IMVT current market cap is $9B, up +250.52% over the past 365 days
- Revenue
- IMVT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for IMVT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Immunovant, Inc. |
| Ticker | NASDAQ: IMVT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | immunovant.com |
| Employees | 362 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $44.30 | |
| Price, 1D Change | +1.35% | |
| $9B | ||
| - | ||
| - | ||
| 1.36 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.77 | ||
| EPS, 1Y Change | -1.51% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | HSAC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.77 | ||
| EPS Estimate | -$2.92 | N/A |
| EPS Est. Change | -5.37% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $44.30 | |
| Price Target | $48.50 | - |
| Price Tgt. Change | +9.48% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.87 | -$2.73 | +5.00% | |
| -$2.61 | -$2.77 | -6.26% | |
| -$2.92 | N/A | -5.37% | |
| -$2.50 | N/A | +9.82% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $37.34M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $44.30 | |
| $29.36 | ||
| $38.47 | ||
| $30.55 | ||
| $38.27 | ||
| $1.31 | ||
| 1.36 | ||
| $1.57 | ||
| 72.64 | ||
| 31.83% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.77 | ||
| $0.00 | ||
| - | ||
| -$532.90M | ||
| - | ||
| -$505.61M | ||
| - | ||
| -$532.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 9.09 | ||
| 9.09 | ||
| - | ||
| - | ||
| 48.97 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 12.44 | ||
| -14.77 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $852.59M | ||
| $902.11M | ||
| $957.57M | ||
| $948.82M | ||
| $104.98M | ||
| $104.42M | ||
| $72.00K | ||
| $72.00K | ||
| $7.54M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $505.61M | ||
| $532.90M | ||
| $0.00 | ||
| $0.00 | ||
| $409.00K | ||
| $0.00 | ||
| $215.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$407.31M | ||
| -$8,000.00 | ||
| $595.76M | ||
| $8,000.00 | ||
| -$407.32M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| Citigroup | → | |
| Guggenheim | → | |
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Goldman Sachs | → | |
| Bernstein | ||
| HC Wainwright & Co. | → | |
| Guggenheim | → |
Analyst sentiment
Institutional ownership
Screeners with IMVT
FAQ
- What is the ticker symbol for Immunovant, Inc.?
- The ticker symbol for Immunovant, Inc. is NASDAQ:IMVT
- Does Immunovant, Inc. pay dividends?
- No, Immunovant, Inc. does not pay dividends
- What sector is Immunovant, Inc. in?
- Immunovant, Inc. is in the Healthcare sector
- What industry is Immunovant, Inc. in?
- Immunovant, Inc. is in the Biotechnology industry
- What country is Immunovant, Inc. based in?
- Immunovant, Inc. is headquartered in United States
- When did Immunovant, Inc. go public?
- Immunovant, Inc. initial public offering (IPO) was on June 21, 2019
- Is Immunovant, Inc. in the S&P 500?
- No, Immunovant, Inc. is not included in the S&P 500 index
- Is Immunovant, Inc. in the NASDAQ 100?
- No, Immunovant, Inc. is not included in the NASDAQ 100 index
- Is Immunovant, Inc. in the Dow Jones?
- No, Immunovant, Inc. is not included in the Dow Jones index
- When was Immunovant, Inc. last earnings report?
- Immunovant, Inc.'s most recent earnings report was on August 6, 2026
- When does Immunovant, Inc. report earnings?
- The next expected earnings date for Immunovant, Inc. is November 9, 2026
Data Sources & References
- IMVT Official Website immunovant.com
- IMVT Profile on Yahoo Finance finance.yahoo.com/quote/IMVT
- IMVT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imvt